Metformin improves cancer immunotherapy by directly rescuing tumor-infiltrating CD8 T lymphocytes from hypoxia-induced immunosuppression
<p><strong>Background</strong> Despite their revolutionary success in cancer treatment over the last decades, immunotherapies encounter limitations in certain tumor types and patients. The efficacy of immunotherapies depends on tumor antigen-specific CD8 T-cell viability and functi...
| Κύριοι συγγραφείς: | , , , , , , |
|---|---|
| Μορφή: | Journal article |
| Γλώσσα: | English |
| Έκδοση: |
BMJ Publishing Group
2023
|
| _version_ | 1826310746458292224 |
|---|---|
| author | Finisguerra, V Dvorakova, T Formenti, M Van Meerbeeck, P Mignion, L Gallez, B Van den Eynde, BJ |
| author_facet | Finisguerra, V Dvorakova, T Formenti, M Van Meerbeeck, P Mignion, L Gallez, B Van den Eynde, BJ |
| author_sort | Finisguerra, V |
| collection | OXFORD |
| description | <p><strong>Background</strong> Despite their revolutionary success in cancer treatment over the last decades, immunotherapies encounter limitations in certain tumor types and patients. The efficacy of immunotherapies depends on tumor antigen-specific CD8 T-cell viability and functionality within the immunosuppressive tumor microenvironment, where oxygen levels are often low. Hypoxia can reduce CD8 T-cell fitness in several ways and CD8 T cells are mostly excluded from hypoxic tumor regions. Given the challenges to achieve durable reduction of hypoxia in the clinic, ameliorating CD8 T-cell survival and effector function in hypoxic condition could improve tumor response to immunotherapies.</p>
<p><strong>Methods</strong> Activated CD8 T cells were exposed to hypoxia and metformin and analyzed by fluorescence-activated cell sorting for cell proliferation, apoptosis and phenotype. In vivo, metformin was administered to mice bearing hypoxic tumors and receiving either adoptive cell therapy with tumor-specific CD8 T cells, or immune checkpoint inhibitors; tumor growth was followed over time and CD8 T-cell infiltration, survival and localization in normoxic or hypoxic tumor regions were assessed by flow cytometry and immunofluorescence. Tumor oxygenation and hypoxia were measured by electron paramagnetic resonance and pimonidazole staining, respectively.</p>
<p><strong>Results</strong> We found that the antidiabetic drug metformin directly improved CD8 T-cell fitness in hypoxia, both in vitro and in vivo. Metformin rescued murine and human CD8 T cells from hypoxia-induced apoptosis and increased their proliferation and cytokine production, while blunting the upregulation of programmed cell death protein 1 and lymphocyte-activation gene 3. This appeared to result from a reduced production of reactive oxygen species, due to the inhibition of mitochondrial complex I. Differently from what others reported, metformin did not reduce tumor hypoxia, but rather increased CD8 T-cell infiltration and survival in hypoxic tumor areas, and synergized with cyclophosphamide to enhance tumor response to adoptive cell therapy or immune checkpoint blockade in different tumor models.</p>
<p><strong>Conclusions</strong> This study describes a novel mechanism of action of metformin and presents a promising strategy to achieve immune rejection in hypoxic and immunosuppressive tumors, which would otherwise be resistant to immunotherapy.</p> |
| first_indexed | 2024-03-07T07:58:00Z |
| format | Journal article |
| id | oxford-uuid:bf8c46e9-6df8-4943-8e3a-bc8c3f7c7d21 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T07:58:00Z |
| publishDate | 2023 |
| publisher | BMJ Publishing Group |
| record_format | dspace |
| spelling | oxford-uuid:bf8c46e9-6df8-4943-8e3a-bc8c3f7c7d212023-08-29T16:54:54ZMetformin improves cancer immunotherapy by directly rescuing tumor-infiltrating CD8 T lymphocytes from hypoxia-induced immunosuppressionJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:bf8c46e9-6df8-4943-8e3a-bc8c3f7c7d21EnglishSymplectic ElementsBMJ Publishing Group2023Finisguerra, VDvorakova, TFormenti, MVan Meerbeeck, PMignion, LGallez, BVan den Eynde, BJ<p><strong>Background</strong> Despite their revolutionary success in cancer treatment over the last decades, immunotherapies encounter limitations in certain tumor types and patients. The efficacy of immunotherapies depends on tumor antigen-specific CD8 T-cell viability and functionality within the immunosuppressive tumor microenvironment, where oxygen levels are often low. Hypoxia can reduce CD8 T-cell fitness in several ways and CD8 T cells are mostly excluded from hypoxic tumor regions. Given the challenges to achieve durable reduction of hypoxia in the clinic, ameliorating CD8 T-cell survival and effector function in hypoxic condition could improve tumor response to immunotherapies.</p> <p><strong>Methods</strong> Activated CD8 T cells were exposed to hypoxia and metformin and analyzed by fluorescence-activated cell sorting for cell proliferation, apoptosis and phenotype. In vivo, metformin was administered to mice bearing hypoxic tumors and receiving either adoptive cell therapy with tumor-specific CD8 T cells, or immune checkpoint inhibitors; tumor growth was followed over time and CD8 T-cell infiltration, survival and localization in normoxic or hypoxic tumor regions were assessed by flow cytometry and immunofluorescence. Tumor oxygenation and hypoxia were measured by electron paramagnetic resonance and pimonidazole staining, respectively.</p> <p><strong>Results</strong> We found that the antidiabetic drug metformin directly improved CD8 T-cell fitness in hypoxia, both in vitro and in vivo. Metformin rescued murine and human CD8 T cells from hypoxia-induced apoptosis and increased their proliferation and cytokine production, while blunting the upregulation of programmed cell death protein 1 and lymphocyte-activation gene 3. This appeared to result from a reduced production of reactive oxygen species, due to the inhibition of mitochondrial complex I. Differently from what others reported, metformin did not reduce tumor hypoxia, but rather increased CD8 T-cell infiltration and survival in hypoxic tumor areas, and synergized with cyclophosphamide to enhance tumor response to adoptive cell therapy or immune checkpoint blockade in different tumor models.</p> <p><strong>Conclusions</strong> This study describes a novel mechanism of action of metformin and presents a promising strategy to achieve immune rejection in hypoxic and immunosuppressive tumors, which would otherwise be resistant to immunotherapy.</p> |
| spellingShingle | Finisguerra, V Dvorakova, T Formenti, M Van Meerbeeck, P Mignion, L Gallez, B Van den Eynde, BJ Metformin improves cancer immunotherapy by directly rescuing tumor-infiltrating CD8 T lymphocytes from hypoxia-induced immunosuppression |
| title | Metformin improves cancer immunotherapy by directly rescuing tumor-infiltrating CD8 T lymphocytes from hypoxia-induced immunosuppression |
| title_full | Metformin improves cancer immunotherapy by directly rescuing tumor-infiltrating CD8 T lymphocytes from hypoxia-induced immunosuppression |
| title_fullStr | Metformin improves cancer immunotherapy by directly rescuing tumor-infiltrating CD8 T lymphocytes from hypoxia-induced immunosuppression |
| title_full_unstemmed | Metformin improves cancer immunotherapy by directly rescuing tumor-infiltrating CD8 T lymphocytes from hypoxia-induced immunosuppression |
| title_short | Metformin improves cancer immunotherapy by directly rescuing tumor-infiltrating CD8 T lymphocytes from hypoxia-induced immunosuppression |
| title_sort | metformin improves cancer immunotherapy by directly rescuing tumor infiltrating cd8 t lymphocytes from hypoxia induced immunosuppression |
| work_keys_str_mv | AT finisguerrav metforminimprovescancerimmunotherapybydirectlyrescuingtumorinfiltratingcd8tlymphocytesfromhypoxiainducedimmunosuppression AT dvorakovat metforminimprovescancerimmunotherapybydirectlyrescuingtumorinfiltratingcd8tlymphocytesfromhypoxiainducedimmunosuppression AT formentim metforminimprovescancerimmunotherapybydirectlyrescuingtumorinfiltratingcd8tlymphocytesfromhypoxiainducedimmunosuppression AT vanmeerbeeckp metforminimprovescancerimmunotherapybydirectlyrescuingtumorinfiltratingcd8tlymphocytesfromhypoxiainducedimmunosuppression AT mignionl metforminimprovescancerimmunotherapybydirectlyrescuingtumorinfiltratingcd8tlymphocytesfromhypoxiainducedimmunosuppression AT gallezb metforminimprovescancerimmunotherapybydirectlyrescuingtumorinfiltratingcd8tlymphocytesfromhypoxiainducedimmunosuppression AT vandeneyndebj metforminimprovescancerimmunotherapybydirectlyrescuingtumorinfiltratingcd8tlymphocytesfromhypoxiainducedimmunosuppression |